Equillium, Inc.: RA CAPITAL MANAGEMENT, L.P. amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
RA Capital Management, L.P. amended its Schedule 13G filing for Equillium, Inc. with the SEC under accession number 0001346824-26-000279. The amendment updates the firm's previously reported beneficial ownership position in the clinical-stage biopharmaceutical company. Schedule 13G filings are required of investors holding passive stakes above 5% of a class of securities, and amendments typically reflect changes in holdings or internal reporting. The specific size and direction of the stake change were not disclosed in the filing headline. Investors will watch for further 13G or 13D filings to gauge whether RA Capital's position continues to shift.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
RA Capital Management, L.P., Equillium, Inc.